Emily Neil

Title: Emily Neil - Innovator in Spatial Multiomics Technology

Introduction

Emily Neil is a pioneering inventor based in Bergisch Gladbach, Germany. She has made significant contributions to the field of spatial multiomics through her innovative research and development. Her work focuses on advancing microscopy imaging techniques that allow for the spatial resolution of multiple mRNAs, proteins, and metabolites at a subcellular level.

Latest Patents

Emily Neil holds a patent for her invention titled "Method and instrumentation for spatial multiomics using SUMI-technology." This groundbreaking method, known as SUMI-Seq, combines Spatial Unique Molecular Identifier in situ sequencing with in vitro sequencing of rolonies derived from rolling circle amplification. This technology targets portions of RNA or cDNA transcripts at a subcellular level, overcoming limitations in transcript quantity and sequence length analysis. The SUMI-Seq method can also utilize circular oligonucleotides to spatially resolve proteins and metabolites, providing comprehensive multiomics results.

Career Highlights

Emily is currently employed at Miltenyi Biotec B.V. & Co. KG, where she continues to push the boundaries of scientific research. Her work is crucial for understanding tissue heterogeneity, particularly within the tumor microenvironment.

Collaborations

Emily collaborates with esteemed colleagues, including Thomas Rothmann and Robert Pinard, to further enhance the impact of her research in the field of multiomics.

Conclusion

Emily Neil's innovative contributions to spatial multiomics technology exemplify her dedication to advancing scientific knowledge. Her patented methods and ongoing research are vital for understanding complex biological systems and have the potential to revolutionize the field.